Kanofsky Jacob Daniel, Viswanathan Shankar, Wylie-Rosett Judith
Bronx Psychiatric Center, Bronx, NY, USA (JDK); Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA (JDK); Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA (SV, JWR); and New York Regional Center for Diabetes Translational Research, Albert Einstein College of Medicine, Bronx, NY, USA (JWR).
Am J Lifestyle Med. 2022 Dec 1;18(2):156-161. doi: 10.1177/15598276221142307. eCollection 2024 Mar-Apr.
This commentary critiques the Danish CHANGE trial, which evaluated 3 levels of outpatient intervention intensity, in a group of outpatients with obesity and schizophrenia. Neither adding care coordination with weekly nurse contacts alone nor combining this treatment with assertive community lifestyle coaching as compared to treatment as usual improved outcomes, which included cardiovascular disease risk calculation, cardiorespiratory fitness, weight, and self-reported behaviors such as smoking, physical activity, and diet. The CHANGE trial investigators appear strongly averse to recommending the development and implementation of lifestyle medicine programs as a major component when treating outpatients with severe mental disorders. The potential dismissal of lifestyle medicine as a component of treatment for severe mental disorders is problematic. Valuable lessons can be learned from more thoroughly analyzing secondary outcomes such as medical and psychiatric hospitalization rates and total health care cost. The CHANGE trial data analysis needs to be expanded beyond the focus on changes in weight and serum cholesterol. Insulin resistance and high refined carbohydrate intake may be major factors in determining both the medical and psychiatric clinical course of schizophrenia. Assertive community lifestyle coaching is a novel treatment modality. Evidence strongly suggests assertive community lifestyle coaching substantially decreases both psychiatric and medical hospitalization rates.
本评论对丹麦的CHANGE试验进行了批判,该试验在一组肥胖且患有精神分裂症的门诊患者中评估了3种门诊干预强度水平。与常规治疗相比,仅增加每周与护士联系的护理协调,或将这种治疗与积极的社区生活方式指导相结合,均未改善结果,这些结果包括心血管疾病风险计算、心肺适能、体重以及自我报告的行为,如吸烟、体育活动和饮食。CHANGE试验的研究者似乎强烈反对将生活方式医学项目的开发和实施作为治疗重度精神障碍门诊患者的主要组成部分。将生活方式医学排除在重度精神障碍治疗组成部分之外可能存在问题。通过更全面地分析诸如医疗和精神科住院率以及总医疗费用等次要结果,可以吸取宝贵的经验教训。CHANGE试验的数据分析需要从仅关注体重和血清胆固醇的变化扩展。胰岛素抵抗和高精制碳水化合物摄入量可能是决定精神分裂症医学和精神科临床病程的主要因素。积极的社区生活方式指导是一种新型治疗方式。有力证据表明,积极的社区生活方式指导可大幅降低精神科和医疗住院率。